SB-415286

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSB-415286
Drug Alias NameSB-415286
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 inhibitors
TargetsGlycogen synthase kinase-3
Therapy Area/IndicationsNerve DegenerationDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSmithkline Beecham
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSmithkline Beecham
Active IndicationsN/A
Inactive IndicationsNerve DegenerationDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A